William Woods
Stock Analyst at B. Riley Securities
(1.60)
# 3,493
Out of 5,241 analysts
16
Total ratings
43.75%
Success rate
-3.79%
Average return
Main Sectors:
Stocks Rated by William Woods
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Maintains: Buy | $8 → $7 | $4.36 | +60.55% | 1 | May 15, 2026 | |
| EQ Equillium | Initiates: Buy | $6 | $1.84 | +226.09% | 1 | Apr 16, 2026 | |
| KRMD KORU Medical Systems | Maintains: Buy | $7 → $8 | $3.83 | +108.88% | 2 | Mar 13, 2026 | |
| ALT Altimmune | Maintains: Buy | $18 → $13 | $2.80 | +364.29% | 1 | Mar 6, 2026 | |
| PALI Palisade Bio | Initiates: Buy | $7 | $1.81 | +286.74% | 1 | Jan 9, 2026 | |
| MDGL Madrigal Pharmaceuticals | Maintains: Buy | $560 → $670 | $522.23 | +28.30% | 1 | Dec 11, 2025 | |
| OKYO OKYO Pharma | Initiates: Buy | $5 | $1.59 | +214.47% | 1 | Dec 8, 2025 | |
| CGTX Cognition Therapeutics | Reiterates: Buy | $2 → $3 | $1.09 | +175.23% | 1 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $12 → $10 | $4.24 | +135.85% | 3 | Nov 18, 2025 | |
| IMUX Immunic | Reiterates: Buy | $60 → $50 | $11.66 | +328.82% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $2.12 | +2,258.49% | 1 | May 14, 2024 |
Aardvark Therapeutics
May 15, 2026
Maintains: Buy
Price Target: $8 → $7
Current: $4.36
Upside: +60.55%
Equillium
Apr 16, 2026
Initiates: Buy
Price Target: $6
Current: $1.84
Upside: +226.09%
KORU Medical Systems
Mar 13, 2026
Maintains: Buy
Price Target: $7 → $8
Current: $3.83
Upside: +108.88%
Altimmune
Mar 6, 2026
Maintains: Buy
Price Target: $18 → $13
Current: $2.80
Upside: +364.29%
Palisade Bio
Jan 9, 2026
Initiates: Buy
Price Target: $7
Current: $1.81
Upside: +286.74%
Madrigal Pharmaceuticals
Dec 11, 2025
Maintains: Buy
Price Target: $560 → $670
Current: $522.23
Upside: +28.30%
OKYO Pharma
Dec 8, 2025
Initiates: Buy
Price Target: $5
Current: $1.59
Upside: +214.47%
Cognition Therapeutics
Nov 21, 2025
Reiterates: Buy
Price Target: $2 → $3
Current: $1.09
Upside: +175.23%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.24
Upside: +135.85%
Immunic
May 23, 2025
Reiterates: Buy
Price Target: $60 → $50
Current: $11.66
Upside: +328.82%
May 14, 2024
Initiates: Buy
Price Target: $50
Current: $2.12
Upside: +2,258.49%